Observational Study of Baska Mask, a New Supraglottic Airway Device
NCT ID: NCT01496859
Last Updated: 2012-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
30 participants
INTERVENTIONAL
2011-08-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the BASKA Airway, a Novel Supraglottic Device, to the LMA Airway in Low Risk Female Patients
NCT01482650
Observational Study of Baska Mask, a New Supraglottic Airway Device in Children
NCT01625078
Determination of the Optimal Approach to Select the Best Size of BASKA Mask to Use in Male Patients
NCT01625052
Comparison of the Baska Mask Airway to a Single-use LMA Device in Low-risk Female Patients
NCT01753635
Respiration and The Airway With Laryngeal Masks
NCT03542890
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Baska
Placement and use of Baska mask
use of a supraglottic airway device as a standard part of a general anaesthetic
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placement and use of Baska mask
use of a supraglottic airway device as a standard part of a general anaesthetic
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No relevant drug allergies
* Body-mass index (BMI) 20-35
* Age 18-65
* Non-urgent surgery of planned duration 0-2 hrs
Exclusion Criteria
* Non-English speakers
* Neck pathology
* Previous or anticipated problems with the upper airway or upper GI tract (reflux, hiatus hernia, oropharyngeal tumour, upper respiratory tract infection in the last 10 days etc)
* BMI \>35
* Expected Difficult airway
* Live Pregnancy
* Increased risk for Gastric Aspiration
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University College Hospital Galway
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
John Laffey
Professor of Anaesthesia and Critical Care, Consultant Anaesthetist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John G Laffey, FFARCSI
Role: PRINCIPAL_INVESTIGATOR
National University of Ireland, Galway and Galway University Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Galway University Hospitals
Galway, Galway, Ireland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C.A.621
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.